8-K ·Filed Jul 24, 2026

ONMD

OneMedNet Corp
NEUTRAL
Impact 2/10
Horizonweeks Processed2mo ago SEC0001493152-26-034599
Actionable Insight • Neutral

This filing is purely administrative — no trading signal. Monitor for the definitive proxy statement and any stockholder proposals or director nominations that may surface before the August 5 deadline, which could indicate activist interest.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
ONMD ▼ -2.61% at T+20d
NEUTRAL call ✗ call lost -2.61% · α vs SPY -5.91% · entry $0.6059 → $0.5901
Next anchor: T+60d in 17d
Latest observation: T+46 +37.24% FF3 residual α
Entry anchored
Jul 24, 03:55 PM ET
via exchange tick
T+1d
+17.02%
call +17.02% · α +16.78%
$0.7090
settled 2mo ago
T+5d
+18.80%
call +18.80% · α +17.72%
$0.7198
settled 2mo ago
T+20d
-2.61%
call -2.61% · α -5.91%
$0.5901
settled 6w ago
T+60d
—
call — · α —
—
in 17d

Price Chart

Loading chart...

Executive Summary

OneMedNet filed an 8-K setting September 18, 2026 as the date for its 2026 Annual Meeting, with an August 11 record date and an August 5, 2025 deadline for stockholder proposals and director nominations. The meeting date was moved more than 30 days from the December 17, 2025 annual meeting, triggering updated deadlines under SEC rules. This is a routine procedural filing with no financial or operational impact — it simply establishes the governance calendar for the upcoming annual meeting.

Key Facts

  • 2026 Annual Meeting set for September 18, 2026
  • Record date for voting is August 11, 2026
  • Deadline for stockholder proposals and director nominations is August 5, 2026
  • Meeting date changed by more than 30 days from the December 17, 2025 annual meeting
  • No financial data, operational updates, or material events disclosed

Financial Impact

None — purely procedural filing with no financial figures

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (ONMD) — Batch item 10001493152-26-034599
Document: 0001493152-26-034599-index-headers.html0001493152-26-034599
Document: 0001493152-26-034599-index.html0001493152-26-034599
Document: 0001493152-26-034599.txt0001493152-26-034599
8-K Filing (ONMD) — Batch item 50001493152-26-034599
Document: 0001493152-26-034599-index-headers.html0001493152-26-034599
Document: 0001493152-26-034599-index.html0001493152-26-034599
Document: 0001493152-26-034599.txt0001493152-26-034599
7 reports for ONMD
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +45.02%Jun 16, 2026
Filters
Rows
Reports for ONMD — sortable, filterable
TypeNow
Jul 24, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$0.6059 $0.5901▼ −2.61%▼ −5.91%$5.39 (+789.59%)
Jul 13, 2026
11w ago
EFFECT
NEUTRAL ★ 3/10
$0.7457 $0.6600▼ −11.49%▼ −14.68%$5.39 (+622.81%)
Jun 17, 2026
15w ago
Insider Cluster
BULLISH ★ 6/10
$0.6023 $0.6901▲ +14.58%▲ +13.26%$5.39 (+794.90%)
Jun 16, 2026
15w ago
Insider Cluster
BULLISH ★ 6/10
$0.5011 $0.7267▲ +45.02%▲ +44.82%$5.39 (+975.63%)
Apr 6, 2026
25w ago
Press Release
BULLISH ★ 8/10
$0.9520 $1.05▲ +10.29%▲ +1.31%$5.39 (+466.18%)
Apr 1, 2026
26w ago
Press Release
NEUTRAL ★ 4/10
$0.8440 $1.08▲ +27.96%▲ +18.24%$5.39 (+538.63%)
Mar 18, 2026
28w ago
Press Release
MIXED ★ 5/10
$0.8190 $0.8870▲ +8.30%▲ +2.26%$5.39 (+558.12%)
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (38h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access